Saturday, November 23, 2024
spot_img

India’s first intranasal vaccine for COVID gets DCGI approval

Date:

Share post:

spot_img
spot_img

New Delhi, Sep 6:  India’s first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation.

Announcing the achievements, Union Health Minister Mansukh Mandaviya termed it a ‘big boost to India’s fight against Covid-19.

“Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation,” Mandaviya tweeted.

In the subsequent tweet he said, “This step will further strengthen our collective fight against the pandemic.

“India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership. With the science-driven approach & Sabka Prayas, we will defeat COVID-19”, he said.

IANS
spot_img
spot_img

Related articles

Rally against ‘illegal’ sand mining in Dudhnoi river

DAINADUBI/DUDHNOI, Nov 22: More than 15 Civil Society Organisations (CSOs) from Meghalaya, members of the All Bodo Students'...

News Capsule

Guidebooks The Meghalaya Board of School Education (MBoSE) has informed all non-regular and compartmental students, registered to appear for...

Govt aiming to simplify mining license process, says Tynsong

SHILLONG, Nov 22: Deputy Chief Minister Prestone Tynsong on Friday said that the state government is working to...

Assembly committee contented with progress of Smart City projects

SHILLONG, Nov 22: The Estimates Committee of the Meghalaya Legislative Assembly has expressed satisfaction with the progress of...